Multitrace Deformations of Vector and Adjoint Theories and their Holographic Duals

We present general methods to study the effect of multitrace deformations in conformal theories admitting holographic duals in Anti de Sitter space. In particular, we analyse the case that these deformations introduce an instability both in the bulk AdS space and in the boundary CFT. We also argue that multitrace deformations of the O(N) linear sigma model in three dimensions correspond to nontrivial time-dependent backgrounds in certain theories of infinitely many interacting massless fields on AdS_4, proposed years ago by Fradkin and Vasiliev. We point out that the phase diagram of a truly marginal large-N deformation has an infrared limit in which only an O(N) singlet field survives. We draw from this case lessons on the full string-theoretical interpretation of instabilities of the dual boundary theory and exhibit a toy model that resolves the instability of the O(N) model, generated by a marginal multitrace deformation. The resolution suggests that the instability may not survive in an appropriate UV completion of the CFT.Comment: 18 pages, minor changes, references added. Version accepted by JHE

Removing Singularities

Big bang/crunch curvature singularities in exact CFT string backgrounds can be removed by turning on gauge fields. This is described within a family of {SL(2)xSU(2)xU(1)_x}/{U(1)xU(1)} quotient CFTs. Uncharged incoming wavefunctions from the ``whiskers'' of the extended universe can be fully reflected if and only if a big bang/crunch curvature singularity, from which they are scattered, exists. Extended BTZ-like singularities remain as long as U(1)_x is compact.Comment: 21 pages, harvma

Incident gout and chronic Kidney Disease: healthcare utilization and survival

Abstract Background Uncontrolled gout can cause significant joint and organ damage and has been associated with impairments in quality of life and high economic cost. Gout has also been associated with other comorbid diseases, such as chronic kidney disease. The current study explored if healthcare resource utilization (HRU) and survival differs between patients with incident gout in the presence or absence of chronic kidney disease (CKD). Methods Clalit Health Services (CHS) data were used to conduct a retrospective population-based cohort study of incident gout between 1/1/2006–31/12/2009. Incident cases of gout were identified and stratified by CKD status and by age group (< 55 and 55+ years). CKD status was defined as a pre-existing diagnosis of chronic kidney disease, chronic renal failure, kidney transplantation, or dialysis at index date. Demographic and clinical characteristics, as well as healthcare resource use, were reported. Results A total of 12,940 incident adult gout patients, with (n = 8286) and without (n = 4654) CKD, were followed for 55,206 person-years. Higher rates of HRU were observed for gout patients with CKD than without. Total annual hospital admissions for patients with gout and CKD were at least 3 times higher for adults < 55 (mean = 0.51 vs 0.13) and approximately 1.5 times higher for adults 55+ (mean = 0.46 vs 0.29) without CKD. Healthcare utilization rates from year 1 to year 5 remained similar for gout patients < 55 years irrespective of CKD status, however varied according to healthcare utilization by CKD status for gout patients 55+ years. The 5-year all-cause mortality was higher among those with CKD compared to those without CKD for both age groups (HR< 55 years = 1.65; 95% CI 1.01–2.71; HR55+ years = 1.50; 95% CI 1.37–1.65). Conclusions The current study suggests important differences exist in patient characteristics and outcomes among patients with gout and CKD. Healthcare utilization differed between sub-populations, age and comorbidities, over the study period and the 5-year mortality risk was higher for gout patients with CKD, regardless of age. Future work should explore factors associated with these outcomes and barriers to gout control in order to enhance patient management among this high-risk subgroup